ライフサイエンスコーパス: medical genetics

1 lecular diagnosis and research activities in medical genetics.

2 quencing (NGS) technologies have transformed medical genetics.

3 Phenotype prediction is a key goal for medical genetics.

4 ing (WGS), which are now extensively used in medical genetics.

5 interpretation remains a major challenge in medical genetics.

6 ology and genome-wide association studies in medical genetics.

7 led the collective knowledge of the field of medical genetics.

8 ation history, genealogy, forensics and male medical genetics.

9 ck a wealth of information in population and medical genetics.

10 ous application areas from bioengineering to medical genetics.

11 de novo) mutations have an important role in medical genetics.

12 s an important, yet formidable challenge for medical genetics.

13 le method for PS assessment in mitochondrial medical genetics.

14 cent applications of array CGH in cancer and medical genetics.

15 s stand to make the greatest contribution to medical genetics.

16 enomic structures plays an important role in medical genetics.

17 tion of the developing canine linkage map in medical genetics.

18 dicine (0.6%), physical medicine (0.4%), and medical genetics (0.2%) being the least represented.

19 d common diseases is an ongoing challenge in medical genetics(1).

20 ts were classified using American College of Medical Genetics (ACMG) consensus guidelines.

21 ary disorders along with American College of Medical Genetics (ACMG) secondary findings v3.2 were ann

22 f Human Genetics (ASHG), American College of Medical Genetics (ACMG), and the National Academies of S

23 l and genetic data in an American College of Medical Genetics (ACMG)/Association for Molecular Pathol

24 addition, review of the American College of Medical Genetics actionable genes identified a pathogeni

25 In this tutorial, using examples from medical genetics and alternative splicing, I describe so

26 The American College of Medical Genetics and American College of Pathologists (A

27 e specifications for the American College of Medical Genetics and Association for Molecular Pathology

28 application of the 2015 American College of Medical Genetics and Association for Molecular Pathology

29 l actionability with the American College of Medical Genetics and Association for Molecular Pathology

30 yield intriguing potential for translational medical genetics and evolutionary biology, and our appro

31 fore important for molecular, population and medical genetics and for a deeper understanding of the m

32 nce, there is a crucial need in the areas of medical genetics and genome analysis for rapid, accurate

33 deemed actionable by the American College of Medical Genetics and Genomics (ACMG) and 5197 clinically

34 The American College of Medical Genetics and Genomics (ACMG) and Association of

35 In 2015, the American College of Medical Genetics and Genomics (ACMG) and the Association

36 In 2015, the American College of Medical Genetics and Genomics (ACMG) and the Association

37 testing produced by the American College of Medical Genetics and Genomics (ACMG) and the European So

38 LS genes by applying the American College of Medical Genetics and Genomics (ACMG) criteria on whole g

39 ermined according to the American College of Medical Genetics and Genomics (ACMG) criteria, consisten

40 Using the 2015 American College of Medical Genetics and Genomics (ACMG) guidelines for vari

41 ion methodology based on American College of Medical Genetics and Genomics (ACMG) guidelines to defin

42 delines developed by the American College of Medical Genetics and Genomics (ACMG) into a quantitative

43 uman Genetics (ASHG) and American College of Medical Genetics and Genomics (ACMG) jointly published a

44 rent guidelines from the American College of Medical Genetics and Genomics (ACMG) recommend screening

45 In 2021, the American College of Medical Genetics and Genomics (ACMG) recommended reporti

46 in genetic testing, the American College of Medical Genetics and Genomics (ACMG) recommended the eva

47 articipants and used the American College of Medical Genetics and Genomics (ACMG) v.3.2 list of 81 ge

48 MYH7-specific American College of Medical Genetics and Genomics (ACMG) variant classificat

49 sing the criteria of the American College of Medical Genetics and Genomics (ACMG), including the stro

50 rding to criteria of the American College of Medical Genetics and Genomics (ACMG).

51 shed guidelines from the American College of Medical Genetics and Genomics (ACMG).

52 The American College of Medical Genetics and Genomics (ACMG)/Association for Mol

53 The widely used American College of Medical Genetics and Genomics (ACMG)/Association for Mol

54 interpretation using the American College of Medical Genetics and Genomics (ACMG)/Association for Mol

55 An American College of Medical Genetics and Genomics 2013 policy paper suggesti

56 genes (designated by the American College of Medical Genetics and Genomics [ACMG]) were associated wi

57 were assessed using the American College of Medical Genetics and Genomics and Association for Clinic

58 Recommendations from the American College of Medical Genetics and Genomics and the Association for Mo

59 The 2015 American College of Medical Genetics and Genomics and the Association for Mo

60 dds ratios to align with American College of Medical Genetics and Genomics and the Association for Mo

61 d on the criteria of the American College of Medical Genetics and Genomics and the Association for Mo

62 classified according to American College of Medical Genetics and Genomics and the Association for Mo

63 ariants according to the American College of Medical Genetics and Genomics and the Association for Mo

64 er the guidelines of the American College of Medical Genetics and Genomics and the Association for Mo

65 kely pathogenic based on American College of Medical Genetics and Genomics and the Association for Mo

66 y significance using the American College of Medical Genetics and Genomics criteria and the ClinVar d

67 ikely pathogenic by 2015 American College of Medical Genetics and Genomics criteria in recognized dis

68 ssified based on current American College of Medical Genetics and Genomics criteria with incorporatio

69 Using the American College of Medical Genetics and Genomics criteria, the pooled preva

70 function), as defined by American College of Medical Genetics and Genomics criteria.

71 classified according to American College of Medical Genetics and Genomics criteria.

72 n of rare variants using American College of Medical Genetics and Genomics criteria: benign, likely b

73 Following American College of Medical Genetics and Genomics criterion variant adjudica

74 We used the American College of Medical Genetics and Genomics functional assay criteria

75 Vs done according to the American College of Medical Genetics and Genomics guidelines and the French

76 ssified according to the American College of Medical Genetics and Genomics guidelines as VUS, benign/

77 Applying modified American College of Medical Genetics and Genomics Guidelines, 106 variants w

78 classified according to American College of Medical Genetics and Genomics guidelines.

79 accordance with current American College of Medical Genetics and Genomics guidelines.

80 pathogenicity using the American College of Medical Genetics and Genomics guidelines.

81 on of variants following American College of Medical Genetics and Genomics guidelines.

82 ncorporated into current American College of Medical Genetics and Genomics guidelines.

83 pathogenicity using the American College of Medical Genetics and Genomics guidelines.

84 moderate weight per the American College of Medical Genetics and Genomics pathogenicity criteria sch

85 The American College of Medical Genetics and Genomics score correlated with func

86 ing genes, including all American College of Medical Genetics and Genomics Secondary Findings list v3

87 ults in all genes on the American College of Medical Genetics and Genomics Secondary Findings list.

88 ctionable disease genes (American College of Medical Genetics and Genomics Secondary Findings v2.0, A

89 Based on the 2015 American College of Medical Genetics and Genomics Standards and Guidelines,

90 ssified according to the American College of Medical Genetics and Genomics standards of pathogenic (P

91 ying the criteria of the American College of Medical Genetics and Genomics to all published variants

92 a large gene panel with American College of Medical Genetics and Genomics variant classification and

93 models from ClinGen, the American College of Medical Genetics and Genomics, and the Association for M

94 e recommendations of the American College of Medical Genetics and Genomics, based on clinical, somati

95 and guidelines from the American College of Medical Genetics and Genomics, pathogenic/likely pathoge

96 hogenic according to the American College of Medical Genetics and Genomics-classification, (2) appear

97 neticists certified by the American Board of Medical Genetics and Genomics.

98 ded for reporting by the American College of Medical Genetics and Genomics.

99 g to the criteria of the American College of Medical Genetics and Genomics.

100 first publication of the American College of Medical Genetics and Genomics/Association for Medical Pa

101 s recommendations by the American College of Medical Genetics and Genomics/Association for Molecular

102 tion, we implemented the American College of Medical Genetics and Genomics/Association for Molecular

103 were interpreted per the American College of Medical Genetics and Genomics/Association for Molecular

104 ariants according to the American College of Medical Genetics and Genomics/Association for Molecular

105 strong evidence for both American College of Medical Genetics and Genomics/Association for Molecular

106 vidence and utilized the American College of Medical Genetics and Genomics/Association for Molecular

107 While both the American College of Medical Genetics and Genomics/Association for Molecular

108 and reintroduction of 2 American College of Medical Genetics and Genomics/Association of Molecular P

109 pert panel specified the American College of Medical Genetics and Genomics/Association of Molecular P

110 The VCEP reviewed American College of Medical Genetics and Genomics/Association of Molecular P

111 nicity, we used the 2020 American College of Medical Genetics and Genomics/ClinGen CNV interpretation

112 an mutation is important for many aspects of medical genetics and human evolution.

113 Advances in medical genetics and imaging have improved diagnosis and

114 and 4 months (+/-3.4 months) for the general medical genetics and the ophthalmologist-led IRD clinics

115 nths) and 3.5 months (+/-1.8 months) for the medical genetics and the ophthalmologist-led models, res

116 s including evolutionary biology, forensics, medical genetics, and genealogical reconstruction.

117 nducted in multiple US academic dermatology, medical genetics, and medical oncology clinics between J

118 ediatric ophthalmology, neuro-ophthalmology, medical genetics, and neuro-oncology) direct management

119 Genetic Counselors, the Canadian College of Medical Genetics, and the Canadian Association of Geneti

120 For each participant, two medical genetics- and internal medicine-trained clinicia

121 ing a phenotype-enhanced American College of Medical Genetics approach that incorporates new criteria

122 influence on the fields of physiological and medical genetics as well as on evolutionary biology.

123 ariants using up-to-date American College of Medical Genetics-Association for Molecular Pathology (AC

124 ine sequencing analysis at the Department of Medical Genetics at La Timone Hospital (Marseille, Franc

125 ociation tests have been used extensively in medical genetics, but have had virtually no application

126 rious molecular mechanisms in basic biology, medical genetics, cancer research, immunology, infectiou

127 d affected individuals to reduce barriers to medical genetics care and promote equity in precision me

128 were included, with 212 cases from a general medical genetics clinic and 261 from a medical retina cl

129 d on whether they were referred to a general medical genetics clinic or an ophthalmologist-led IRD cl

130 can be made to a medical geneticist and/or a medical genetics clinic.

131 ere recruited from two university-affiliated medical genetics clinics in Seattle and Vancouver, B.C.

132 ing to the modified 2015 American College of Medical Genetics criteria.

133 as defined using adapted American College of Medical Genetics criteria.

134 cing (NGS) has catalyzed a paradigm shift in medical genetics, enabling the identification of disease

135 ional biology; microbiology, immunology, and medical genetics; engineering, imaging, and synthetic ch

136 Subsequent medical genetics evaluation led ultimately to the diagno

137 complete history, full ophthalmological and medical genetics evaluations, and genetic analysis throu

138 f century, pharmacogenetics has--like all of medical genetics--evolved from a discipline with a focus

139 ected in cases; applying American College of Medical Genetics filtering guidelines (to reduce the rat

140 have a wide range of applications, including medical genetics, forensics, and genetic genealogy.

141 The meeting was attended by leaders in medical genetics from the United States and Canada.

142 ilar for variants in the American College of Medical Genetics genes.

143 American College of Medical Genetics guidelines classified 47% of all RYR2 v

144 American College of Medical Genetics guidelines were followed for classifica

145 On the basis of the American College of Medical Genetics guidelines, 6 of 28 (21%) cases had a p

146 ed according to the 2015 American College of Medical Genetics guidelines, and we compared the accurac

147 ically actionable by the American College of Medical Genetics guidelines.

148 as assessed based on the American College of Medical Genetics guidelines.

149 ding to the contemporary American College of Medical Genetics guidelines.

150 re adjudicated using the American College of Medical Genetics guidelines.

151 ation genetics, gene-expression analyses and medical genetics have begun to make complementary inroad

152 hysical Anthropologists, Canadian College of Medical Genetics, Human Genetics Society of Australasia,

153 ent studies have highlighted the advances in medical genetics, imaging techniques, histological varie

154 n disorders, the number of trainees entering medical genetics in recent years has been dwindling.

155 the introduction of substantial coverage of "medical genetics" in the mass media during the past 2 de

156 e Israeli Ministry of Health and all Israeli medical genetics institutes (n = 18) and NICUs (n = 25).

157 te that the introduction of the discourse of medical genetics is correlated with both a statistically

158 A fundamental question in medical genetics is how the genetic background modifies

159 esults suggest that the current discourse of medical genetics is not accurately described as more bio

160 A fundamental goal of medical genetics is the accurate prediction of genotype-

161 A frequent problem in medical genetics is to connect distant relatives with a

162 c service of the Oxford University Hospitals Medical Genetics Laboratories were analyzed.

163 ng data from the Oxford University Hospitals Medical Genetics Laboratories, the Leiden Open Variation

164 cess QA score, using the American College of Medical Genetics Laboratory Practice Committee standards

165 ffort to validate and link variants from the medical genetics literature to an unambiguous reference

166 Shifting from the traditional medical genetics model to the new ophthalmologist-led IR

167 nd Gynecologists and the American College of Medical Genetics now recommend that invasive prenatal di

168 of Asian genomes has hindered population and medical genetics research on Asians, leading to populati

169 ncy to use European ancestry samples hinders medical genetics research, including the use of polygeni

170 the world yet are sorely underrepresented in medical genetics research.

171 able dataset and codebase can be utilized by medical genetics researchers to evaluate, compare, and i

172 yields and the impact of American College of Medical Genetics secondary findings (ACMG SFs).RESULTSMo

173 ellent candidate for the American College of Medical Genetics secondary gene list.

174 ng an increasingly valuable model species in medical genetics, showing particular promise to advance

175 ended phenotype-enhanced American College of Medical Genetics standards dropped the VUS rate signific

176 in bioethics, policy, genetic epidemiology, medical genetics, statistical genetics, and law.

177 ble tool for prioritizing pathogenic STRs in medical genetics studies.

178 isease and they should be included in future medical genetics studies.

179 The RASopathies are defined as a group of medical genetics syndromes that are caused by germ-line

180 atives are being launched that will position medical genetics to work in collaboration with other spe

181 at have resulted in new initiatives to alter medical genetics training and recruit additional trainee

182 Medical genetics typically entails the detailed characte

183 ), and studies using the American College of Medical Genetics variant interpretation standards (65.6%

184 organisms, cell biology, cell signaling and medical genetics we have significantly increased our und